Veterinary Anti-infectives Market by Drug Type (Anti-viral drugs, Anti-bacterial drugs, Parasiticides, Anti-fungal drugs, Others), by Disease type (Dermatological infections, Respiratory infections, Gastrointestinal infections, Ophthalmic infections, Others), by Species type (Farm animals (Cattle, Aqua, Swine, Sheep, Poultry, Others), Companion animals (Canines, Felines, Horses, Rabbits, Others), Route of administration (Oral, Parenteral, Topical, Others), Distribution channel (Veterinary hospitals, Veterinary pharmacies, Online pharmacies, Others) and Geography.  

Purchase Option

$ 3000
$ 4400
$ 6600
$ 8900

Veterinary Anti-infectives Market Size was valued at USD 1.32 billion in 2021, growing at a CAGR of 3.6% from 2022-28. Anti-infectives are substances that have the ability to counter the malfunction caused by foreign bacteria, fungi, virus, parasites, and among others. Anti-infectives are used to prevent or completely cure various infectious diseases. These substances prevent the chances of contracting the infection by making the body immune from the specific bacterial infection. Commonly occurred veterinary infectious diseases include zoonotic diseases and foodborne disorders. Veterinary Anti-infectives Market report gives a comprehensive outlook across the globe with special emphasis on key regions such as North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa (MEA). This report gives historical, current, and future market sizes (US$ Mn) of drug type, disease type, species type, route of administration and end user and geographic regions. This report studies market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, the market report includes regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed the market to better equip clients with possible investment opportunities across the regions (Regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the market report include suppliers, manufacturers, marketers, policymakers. Key Developments: In March 2016, Dechra Pharmaceuticals acquired Putney Inc. for expanding the veterinary products portfolio and development of pipeline products including veterinary anti-infectives. In May 2013, Novabay Pharmaceuticals inked a collaboration agreement with Virbac for exploring uses of veterinary anti-infective drug auriclosene.

Global Veterinary Anti Infectives Market Summary

Study Period


Base Year




Largest Market

North America

Fastest Growing Market

Veterinary Anti Infectives Market Dynamics

Increase in the global animal adoption rate, a rise in the prevalence of foodborne and zoonotic diseases, increase in the R&D activities for innovation of new products, and government initiations for the animal healthcare are anticipated to fuel the veterinary anti-infectives market. Moreover, increase in the preference for healthy meat and other dairy products, a rise in awareness about the animal infectious diseases, lack of awareness about veterinary vaccines, and growing animal healthcare expenditure expected to boost the veterinary anti-infectives market over the forecast period. However, stringent regulatory policies for veterinary medicines and lack of awareness about the anti-infective drugs in underdeveloped regions might hinder the growth of veterinary anti-infectives market.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Global Veterinary Anti Infectives Market Segmentation

  • Anti-viral drugs
  • Anti-bacterial drugs
  • Parasiticides
  • Anti-fungal drugs
  • Others
  • Veterinary hospitals,
  • Veterinary pharmacies
  • Online pharmacies
  • Others
Disease Type
  • Dermatological infections
  • Respiratory infections
  • Gastrointestinal infections
  • Ophthalmic infections
  • Others
Species Type
  • Farm animals
    • Cattle
    • Aqua
    • Swine
    • Sheep
    • Poultry
    • Others
  • Companion animals
    • Canines
    • Felines
    • Horses
    • Rabbits
    • Others
  • Oral
  • Parenteral
  • Topical
  • Others

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.


[urltag url='request-table-of-content']

  • Zoetis, Inc. (Pfizer) (U.S)
  • Virbac AH Inc. (France)
  • Sanofi S.A. (France)
  • Boehringer Ingelheim Vetmedica, Inc. (Boehringer Ingelheim) (Germany)
  • Bayer HealthCare LLC, (Bayer AG) (Germany)
  • Merck Animal Health (Merck &co. Inc.) (U.S.)
  • Dechra Pharmaceuticals (U.K.)
  • NovaBay Pharmaceuticals, Inc. (U.S.)